ETF Trends
04-17-2008, 01:20 PM
ETF Trends - Keeping a Grip on Exchange Traded Funds (ETFs)
http://www.etftrends.com/images/2008/04/17/reports.jpg (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/reports.jpg) Merrill Lynch (MER (http://finance.yahoo.com/q?s=MER)) posted a first-quarter loss this morning, but so far the broker-dealers exchange traded fund (ETF) seems to be keeping quiet.
The world's largest brokerage said it would cut 3,000 jobs after more than $6.5 billion in fresh write-downs. It's the third consecutive quarterly loss, reports Joe Bel Bruno for the Associated Press (http://biz.yahoo.com/ap/080417/earns_merrill_lynch.html). The firm's CEO went on to warn that the next few quarters could be similarly rough.
Yesterday, the Financial Select Sector SPDRs (XLF (http://finance.yahoo.com/q?s=XLF)) rose for the third consecutive trading day. It's up slightly today, as well - will the winning streak continue? Merrill Lynch is 2% of the fund. Year-to-date it's down 11.3%.
The iShares Dow Jones US Broker-Dealers (IAI (http://finance.yahoo.com/q?s=IAI)) is down just 0.05% midday, and year-to-date it's off by 23.8%. Merrill Lynch is 6.5% of the fund.
http://www.etftrends.com/images/2008/04/17/z_6.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_6.png)
Pfizer (PFE (http://finance.yahoo.com/q?s=PFE)) reported that is first-quarter profit fell by 18%, because of generic drug competition, says the Associated Press (http://biz.yahoo.com/ap/080417/earns_pfizer.html). The numbers were short of estimates. The company also was hurt by the loss of patent protections for drugs such as Norvasc and Zyrtec. The world's best-selling drug, Lipitor, is going to lose its patent protection in 2010. It's a key source of revenue for the company.
Pfizer is 17.6% of the Pharmaceutical HOLDRs (PPH (http://finance.yahoo.com/q?s=PPH)), which are down just over 1% midday. Year-to-date, it's down 10.8%.
[/URL]
[URL="http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_4.png"]http://www.etftrends.com/images/2008/04/17/z_4.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_3.png)
IBM (IBM (http://finance.yahoo.com/q?s=ibm)) delivered some good news: they boasted a 26% rise in profits, surpassing expectations, according to Tim Paradis for the Associated Press (http://biz.yahoo.com/ap/080417/wall_street.html).
IBM is 31.89% of the Internet Architecture HOLDRs (IAH (http://finance.yahoo.com/q?s=IAH)), which is up less than 1% midday. Year-to-date, it's down 8.2%.
http://www.etftrends.com/images/2008/04/17/z_5.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_5.png)
complete story here... (http://feeds.feedburner.com/~r/etftrends-feed/~3/272334685/merrill-lynch-e.html)
http://www.etftrends.com/images/2008/04/17/reports.jpg (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/reports.jpg) Merrill Lynch (MER (http://finance.yahoo.com/q?s=MER)) posted a first-quarter loss this morning, but so far the broker-dealers exchange traded fund (ETF) seems to be keeping quiet.
The world's largest brokerage said it would cut 3,000 jobs after more than $6.5 billion in fresh write-downs. It's the third consecutive quarterly loss, reports Joe Bel Bruno for the Associated Press (http://biz.yahoo.com/ap/080417/earns_merrill_lynch.html). The firm's CEO went on to warn that the next few quarters could be similarly rough.
Yesterday, the Financial Select Sector SPDRs (XLF (http://finance.yahoo.com/q?s=XLF)) rose for the third consecutive trading day. It's up slightly today, as well - will the winning streak continue? Merrill Lynch is 2% of the fund. Year-to-date it's down 11.3%.
The iShares Dow Jones US Broker-Dealers (IAI (http://finance.yahoo.com/q?s=IAI)) is down just 0.05% midday, and year-to-date it's off by 23.8%. Merrill Lynch is 6.5% of the fund.
http://www.etftrends.com/images/2008/04/17/z_6.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_6.png)
Pfizer (PFE (http://finance.yahoo.com/q?s=PFE)) reported that is first-quarter profit fell by 18%, because of generic drug competition, says the Associated Press (http://biz.yahoo.com/ap/080417/earns_pfizer.html). The numbers were short of estimates. The company also was hurt by the loss of patent protections for drugs such as Norvasc and Zyrtec. The world's best-selling drug, Lipitor, is going to lose its patent protection in 2010. It's a key source of revenue for the company.
Pfizer is 17.6% of the Pharmaceutical HOLDRs (PPH (http://finance.yahoo.com/q?s=PPH)), which are down just over 1% midday. Year-to-date, it's down 10.8%.
[/URL]
[URL="http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_4.png"]http://www.etftrends.com/images/2008/04/17/z_4.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_3.png)
IBM (IBM (http://finance.yahoo.com/q?s=ibm)) delivered some good news: they boasted a 26% rise in profits, surpassing expectations, according to Tim Paradis for the Associated Press (http://biz.yahoo.com/ap/080417/wall_street.html).
IBM is 31.89% of the Internet Architecture HOLDRs (IAH (http://finance.yahoo.com/q?s=IAH)), which is up less than 1% midday. Year-to-date, it's down 8.2%.
http://www.etftrends.com/images/2008/04/17/z_5.png (http://etftrends.typepad.com/photos/uncategorized/2008/04/17/z_5.png)
complete story here... (http://feeds.feedburner.com/~r/etftrends-feed/~3/272334685/merrill-lynch-e.html)